Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)

Leukemia Research

Volumn 34, Issue 5, 2010, Pages 594-597

  Medeiros, Bruno C ^a   Kohrt, Holbrook E ^a   Arber, Daniel A ^a   Bangs, Charles D ^a   Cherry, Athena M ^a   Majeti, Ravindra ^a   Kogel, Karen E ^c   Azar, Catherine A ^c   Patel, Samit ^b   Alizadeh, Ash A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

AML; Flow cytometry; Inv(3)(q21q26.2); WHO classification

Indexed keywords

ANTINEOPLASTIC AGENT; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME 3Q; CHROMOSOME INVERSION; CHROMOSOME INVERSION 3; CHROMOSOME TRANSLOCATION 3; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LYMPHOCYTE DIFFERENTIATION; MALE; MONOSOMY 7; MYELOBLAST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CELL SEPARATION; CHROMOSOME INVERSION; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIERS ESTIMATE; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROGNOSIS; YOUNG ADULT;

EID: 77950069794     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.08.029     Document Type: Article

References (12)

1. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO Classification of tumours of haematopoietic and lymphoid tissues 2008, WHO Press, p. 439. 4th ed.
2. Barjesteh van Waalwijk van Doorn-Khosrovani S., Erpelinck C., van Putten W.L., et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003, 101:837-845.
3. Shi G., Weh H.J., Dührsen U., Zeller W., Hossfeld D.K. Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies. Cancer Genet Cytogenet 1997, 96:58-63.
4. Casasnovas R.O., Campos L., Mugneret F., Charrin C., Béné M.C., Garand R., et al. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients. Leukemia 1998, 12:34-43.
5. Fujisawa S., Tanabe J., Harano H., et al. Acute minimally differentiated myeloid leukemia (M0) with inv(3)(q21q26). Leuk Lymphoma 1999, 35:627-630.
6. Glasser L., Meloni-Ehrig A., Greaves W., et al. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation. Transfusion 2009, 49:555-562.
7. Keung Y.K., Buss D., Powell B.L., Pettenati M. Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemia. Cancer Genet Cytogenet 2002, 136:78-81.
8. Wieser R., Schreiner U., Wollenberg B., Neubauer A., Fonatsch C., Rieder H. Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia. Haematologica 2001, 86:214-215.
9. Igarashi T., Shimizu S., Morishita K., Ohtsu T., Itoh K., Minami H., Fujii H., Sasaki Y., Mukai K. Acute myelogenous leukemia with monosomy 7, inv(3)(q21q26), involving activated EVI 1 gene occurring after a complete remission of lymphoblastic lymphoma: a case report. Jpn J Clin Oncol 1998, 28:688-695.
10. Secker-Walker L.M., Mehta A., Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. Br J Haematol 1995, 91:490-501.
11. Paietta E. Immunobiology of acute leukemia. Neoplastic diseases of the blood 1996, 194-231. Churchill Livingstone, New York. 4th ed. P.H. Wiernik (Ed.).
12. ISCN: an International System for Human Cytogenetic Nomenclature 2009, S.Karger, Basel. L.G. Schaffer, M.L. Slovak, L.J. Campbell (Eds.).